nobiletin has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, KJ; Kang, DY; Lee, JM; Sp, N | 1 |
| Charoensinphon, N; Han, Y; Qiu, P; Song, M; Sun, Y; Wu, X; Xiao, H; Zheng, J | 1 |
| Cho, SK; Manh Hung, LV; Moon, JY; Unno, T | 1 |
| Baba, K; Hirata, Y; Ju-ichi, M; Maeda, R; Matsue, S; Nagaoka, Y; Shibano, M; Taniguchi, M; Uesato, S; Yamamoto, M; Yamashita, H | 1 |
| Da, C; Liu, K; Liu, Y; Wang, R; Zhan, Y | 1 |
5 other study(ies) available for nobiletin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Mechanistic Insights of Anti-Immune Evasion by Nobiletin through Regulating miR-197/STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer (NSCLC) Cells.
Topics: A549 Cells; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Flavones; Humans; Lung Neoplasms; MicroRNAs; Neoplasm Proteins; RNA, Neoplasm; Signal Transduction; STAT3 Transcription Factor; Tumor Escape | 2021 |
Inhibitory effects of nobiletin and its major metabolites on lung tumorigenesis.
Topics: Animals; Antioxidants; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Female; Flavones; Humans; Mice; Neoplasms, Experimental; Nitrosamines | 2019 |
Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β⁻Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells.
Topics: A549 Cells; Animals; beta Catenin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Citrus; Doxorubicin; Drug Resistance, Neoplasm; Female; Flavones; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Multidrug Resistance-Associated Proteins; N-Myc Proto-Oncogene Protein; Plant Extracts; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
Synergistic antitumor effect of a combination of paclitaxel and carboplatin with nobiletin from Citrus depressa on non-small-cell lung cancer cell lines.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Citrus; Drug Synergism; Female; Flavones; Humans; Lung Neoplasms; Mice, Inbred BALB C; Paclitaxel; Phytotherapy; Plant Extracts | 2014 |
Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Topics: A549 Cells; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Epithelial-Mesenchymal Transition; Flavones; Humans; Lung Neoplasms; Mice, Nude; Signal Transduction; Smad3 Protein; Transcription, Genetic; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2016 |